Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion: Efficacy of the nonsteroidal antiinflammatory agent, naproxen
Authors:
- Edward F. SmithESEdward F. Smith
- Allan M. LeferALAllan M. Lefer
- 1 April 1981
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 101 (4) , 394-402
Abstract
No abstract availableKeywords
Funding Information
- W. W. Smith Charitable Trust
This publication has 28 references indexed in Scilit:
- Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitroEuropean Journal of Pharmacology, 1980
- Influence of thromboxane inhibition on the severity of myocardial ischemia in catsCanadian Journal of Physiology and Pharmacology, 1980
- A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial InfarctionJAMA, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Studies on the protective effect of prostacyclin in acute myocardial ischemiaEuropean Journal of Pharmacology, 1979
- Effect of indomethacin on collateral blood flow and infarct size in the conscious dog.Circulation, 1979
- Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregationProstaglandins, 1979
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974